Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.84 | N/A |
| PEG Ratio (TTM) | 0.89 | N/A |
| P/S Ratio (TTM) | 3.07 | N/A |
| P/B Ratio (TTM) | 0.95 | N/A |
| P/FCF Ratio (TTM) | 23.55 | N/A |
| Price to 5YR AVG Earnings Ratio | 34.32 | N/A |
| Price to 5YR AVG FCF Ratio | 11.41 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.90% | N/A |
| ROE (TTM) | 6.19% | N/A |
| Net Profit Margin (TTM) | 18.71% | N/A |
| ROIC 5YR AVG | 20.75% | N/A |
Growth (82%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 19.87% | 278.14% | 183.34% |
| Revenue | 3.94% | -4.02% | 4.44% |
| Net Income | 21.25% | 278.91% | 183.96% |
| Cash Flow | 101.43% | 499.52% | 288.38% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 1.23 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.40 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | -0.60% | N/A |